# NABUMETONE
> **ANDA203166** · Abbreviated New Drug Application (Generic) · Sponsor: LGM PHARMA · Approved 2019-08-30
## Drug
- **FDA Application Number:** ANDA203166
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NABUMETONE
- **Generic name:** NABUMETONE
- **Active ingredients:** NABUMETONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LGM PHARMA
- **Manufacturer:** Carwin Pharmaceutical Associates, LLC
- **First approval:** 2019-08-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203166)
---
*AI Analytics · CC0 1.0*